PortViewPortView
Cubist Pharmaceuticals logo

Cubist Pharmaceuticals (CBST) Stock Analysis

NASDAQHealthcareBiotechnology

$101.94-0.04%
52-week range$101.94
$58.50$101.99

What Cubist Pharmaceuticals does

Cubist Pharmaceuticals LLC operates as a pharmaceutical enterprise, concentrating its efforts on the research, development, and market introduction of medical treatments. These treatments are specifically designed to meet substantial, unfulfilled patient needs within critical care environments.

Key metrics

Market cap
$0
P/E (TTM)
0.00
Beta
0.70
50-day avg
$89.25
200-day avg
$72.46
52-week high
$101.99
52-week low
$58.50

ETFs linked to CBST

Broad-market and Healthcare sector ETFs an investor holding Cubist Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CBST fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CBST in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Cubist Pharmaceuticals?
Cubist Pharmaceuticals trades under the ticker CBST on NASDAQ.
Which exchange is CBST listed on?
CBST is listed on NASDAQ.
What sector does Cubist Pharmaceuticals operate in?
Cubist Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CBST in a portfolio?
PortView shows CBST's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.